Patient Outcomes: The Role of CMS Quality Measures
April 7, 2026
The Centers for Medicare & Medicaid Services (CMS) have developed various quality measures to assess healthcare providers’ performance and improve patient care.
CMS Quality Measures and Their Impact on Patient Outcomes
Hospital Readmissions Reduction Program (HRRP):
The HRRP was established by CMS in 2012 to reduce hospital readmissions by penalizing hospitals with higher-than-expected readmission rates for specific conditions (e.g., acute myocardial infarction, heart failure, and pneumonia). Research has shown that the HRRP has led to a significant reduction in readmissions for targeted conditions, with improvements in care coordination and patient transitions1,2.
Hospital Value Based Purchasing (HVBP):
The HVBP Program links a portion of hospitals’ Medicare payments to their performance on a set of quality measures, including patient experience, safety, efficiency, and clinical outcomes. Studies have shown that the HVBP Program has led to modest improvements in patient outcomes and clinical processes3,4.
Merit-Based Incentive Payment System (MIPS):
MIPS is a payment system established by CMS to incentivize clinicians to improve patient care quality by linking Medicare payments to performance on quality, cost, and other measures. Although MIPS is a relatively new program, early evidence suggests that it has the potential to drive improvements in patient care 5,6.
Accountable Care Organizations (ACOs):
ACOs are groups of healthcare providers that voluntarily collaborate to deliver high-quality, coordinated care to Medicare beneficiaries while reducing healthcare costs. Evidence suggests that ACOs have led to improvements in healthcare quality, patient satisfaction, and cost savings7.
Challenges:
Aligning incentives across different quality programs:
The existence of multiple quality programs may lead to misaligned incentives, making it crucial to harmonize these programs to ensure consistent goals and measures.
Balancing quality and cost:
Striking the right balance between improving quality and controlling costs is essential to ensure the long-term sustainability of CMS programs.
Addressing disparities in healthcare:
Future research should focus on understanding and addressing disparities in healthcare access and outcomes among different patient populations.
Evaluating long-term effects:
The long-term impact of CMS quality measures on patient outcomes and healthcare costs remains to be fully understood, warranting further research.
The Centers for Medicare & Medicaid Services (CMS) is responsible for administering federal healthcare programs, including Medicare and Medicaid. As part of its mission to ensure high-quality healthcare, CMS has developed service standards that set expectations for healthcare providers’ performance. These standards aim to enhance patient safety, improve clinical outcomes, and increase patient satisfaction.
CMS Service Standards and Their Influence on Patient Outcomes
Patient Safety:
CMS has established various safety standards to prevent healthcare-associated infections (HAIs), adverse drug events, and other complications. These standards, which include hand hygiene protocols, medication management guidelines, and surgical site infection prevention measures, have contributed to a reduction in HAIs and improved patient safety.
Clinical Outcomes:
CMS has implemented standards for evidence-based care processes, including the appropriate use of medications, screenings, and preventive services. Adherence to these standards has led to better management of chronic conditions, such as diabetes and hypertension, and improved patient outcomes.
Patient Satisfaction:
CMS evaluates patient satisfaction through the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey, which assesses patients’ perceptions of their hospital experience. Hospitals that prioritize patient satisfaction and meet CMS service standards have demonstrated improved patient-reported outcomes and overall patient experience 5,6.
References:
1Zuckerman, R. B., Sheingold, S. H., Orav, E. J., Ruhter, J., & Epstein, A. M. (2016). Readmissions, Observation, and the Hospital Readmissions Reduction Program. New England Journal of Medicine, 374(16), 1543-1551.
2Joynt, K. E., & Jha, A. K. (2016). Characteristics of Hospitals Receiving Penalties Under the Hospital Readmissions Reduction Program. JAMA, 305(5), 101-102.
3Hospital Value-Based Purchasing (HVBP) Program Ryan, A. M., Krinsky, S., Adler-Milstein, J., Damberg, C. L., Maurer, K. A., & Hollingsworth, J. M. (2017). Association Between Hospitals’ Engagement in Value-Based Reforms and Readmission Reduction in the Hospital Readmission Reduction Program. JAMA Internal Medicine, 177(6), 862-868.
4Figueroa, J. F., Tsugawa, Y., Zheng, J., Orav, E. J., & Jha, A. K. (2016). Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study. BMJ, 353, i2214.
5Navathe, A. S., Liao, J. M., Dykstra, S. E., Emanuel, E. J., & Venkataramani, A. S. (2019). Association of Hospital Participation in a Medicare Bundled Payment Program with Volume and Case Mix of Lower Extremity Joint Replacement Episodes. JAMA, 322(9), 880-881.
6Chen, L. M., Meara, E., & Birkmeyer, J. D. (2018). Medicare’s Bundled Payments for Care Improvement Initiative: Effects on Clinical Care Coordination and Patient Experience. Health Services Research, 53(5), 3726-3742.
7McWilliams, J. M., Hatfield, L. A., Chernew, M. E., Landon, B. E., & Schwartz, A. L. (2018). Early Performance of Accountable Care Organizations in Medicare. New England Journal of Medicine, 376(24), 2357-2366.